CN Stock MarketDetailed Quotes

002550 Changzhou Qianhong Biopharma

Watchlist
  • 5.63
  • -0.02-0.35%
Market Closed Aug 19 15:00 CST
7.21BMarket Cap29.32P/E (TTM)

Changzhou Qianhong Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Assets
Current assets
Money funds
28.46%546.18M
45.44%684.25M
40.80%576.23M
-8.68%464.69M
-28.80%425.17M
-42.57%470.47M
-33.76%409.26M
-3.71%508.86M
21.04%597.19M
76.09%819.18M
Transactional financial assets
95.50%94.32M
-51.50%52.53M
6.68%71.98M
-69.47%38.1M
-7.60%48.24M
125.19%108.31M
-1.10%67.48M
33.30%124.78M
25.25%52.21M
-71.33%48.1M
Notes receivable and accounts receivable
-20.34%309.78M
-42.90%286.03M
-59.38%231.93M
-41.95%277.47M
-32.94%388.88M
13.78%500.96M
39.15%571.04M
27.28%477.98M
67.34%579.94M
45.01%440.31M
-Notes receivable
-56.03%3.8M
-27.82%8.2M
15.68%6.9M
-22.13%6.05M
-63.17%8.64M
-44.77%11.37M
-59.29%5.96M
--7.76M
--23.46M
--20.58M
-Accounts receivable
-19.53%305.98M
-43.25%277.83M
-60.18%225.03M
-42.28%271.42M
-31.67%380.24M
16.65%489.6M
42.80%565.08M
25.21%470.22M
60.57%556.48M
38.24%419.73M
Other receivables (including interest and dividends)
53.25%6.48M
20.85%4.63M
580.26%16.9M
773.70%17.86M
53.34%4.23M
54.39%3.83M
-3.01%2.48M
-57.29%2.04M
-46.09%2.76M
-67.78%2.48M
-Accrued interest receivable
--1.12M
----
----
----
----
----
----
----
----
----
-Other receivable
26.69%5.35M
----
580.26%16.9M
----
53.34%4.23M
----
-3.01%2.48M
----
-45.59%2.76M
----
Advance payment
-7.90%18.37M
-80.28%8.45M
-85.90%3.9M
-47.72%31.43M
-51.99%19.94M
-10.63%42.85M
16.88%27.67M
74.41%60.12M
35.15%41.54M
75.89%47.95M
Inventories
-40.39%456.03M
-29.60%499.15M
12.21%602.01M
36.51%674.95M
113.80%765.08M
120.61%709.03M
33.91%536.48M
22.13%494.42M
-14.40%357.85M
-22.82%321.4M
Receivable financing
-40.38%36.04M
-25.47%43.4M
-29.50%43.59M
-42.35%23.42M
360.52%60.46M
156.41%58.23M
65.76%61.82M
-20.96%40.64M
-64.30%13.13M
-74.76%22.71M
Non-current assets due within one year
--20.9M
----
--64.95M
----
----
----
----
----
----
----
Other current assets
1,236.12%4.39M
-92.89%1.19M
31.15%14.49M
82.29%573.53K
-97.57%328.93K
81.44%16.76M
17.89%11.05M
-22.70%314.63K
1,822.37%13.55M
67.10%9.24M
Total current assets
-12.84%1.49B
-17.32%1.58B
-3.63%1.63B
-10.57%1.53B
3.27%1.71B
11.63%1.91B
7.47%1.69B
14.44%1.71B
20.77%1.66B
15.36%1.71B
Non Current assets
Debt investment
-19.27%200.17M
2.10%209.08M
30.25%197.24M
179.27%279.27M
--247.93M
545.15%204.78M
375.05%151.44M
--100M
----
--31.74M
Long-term equity investment
-19.05%2.27M
23.43%5.51M
11.86%5.98M
-29.80%2.89M
-46.48%2.81M
-45.26%4.47M
-38.44%5.34M
-11.17%4.12M
7.54%5.24M
-13.89%8.16M
Fixed assets
-1.52%528.28M
----
-1.64%553.08M
----
-1.87%536.46M
----
-1.79%562.29M
----
9.91%546.68M
----
Constru in process
-89.97%5.96M
----
-84.86%8.19M
----
-9.38%59.42M
----
37.87%54.1M
----
-19.90%65.58M
----
Intangible assets
14.08%111.19M
13.17%112.19M
12.17%113.14M
-10.87%91.37M
-6.13%97.46M
-5.84%99.13M
-5.67%100.86M
-5.58%102.51M
-5.72%103.83M
-6.24%105.28M
Development expenditure
65.00%86.25M
84.22%76.47M
86.25%70.16M
57.74%55.58M
67.98%52.27M
51.63%41.51M
51.86%37.67M
54.98%35.23M
68.23%31.12M
107.05%27.38M
Goodwill
0.00%11.14M
0.00%11.14M
0.00%11.14M
0.00%11.14M
0.00%11.14M
0.00%11.14M
0.00%11.14M
0.00%11.14M
0.00%11.14M
0.00%11.14M
Long deferred expense
12.57%23.4M
3.78%22.52M
4.18%23.6M
-14.05%19.9M
-5.47%20.79M
-1.03%21.7M
2.80%22.66M
-8.00%23.15M
-15.53%21.99M
-14.57%21.92M
Deferred tax assets
-6.62%91.24M
-4.45%93.28M
-10.80%90.53M
-4.63%96.5M
-1.00%97.71M
1.21%97.62M
2.08%101.49M
2.79%101.19M
-2.56%98.7M
-6.36%96.45M
Other non current assets
-9.01%77.9M
8.26%69.75M
-6.46%67.05M
24.51%90.9M
10.82%85.62M
-17.54%64.43M
228.62%71.67M
145.37%73M
198.31%77.25M
203.29%78.13M
Total non current assets
-6.09%1.14B
-0.58%1.15B
1.92%1.14B
13.96%1.21B
26.01%1.21B
17.10%1.16B
19.20%1.12B
21.10%1.06B
9.62%961.53M
11.87%987.06M
Total assets
-10.04%2.63B
-11.01%2.73B
-1.42%2.77B
-1.17%2.74B
11.61%2.92B
13.63%3.07B
11.86%2.81B
16.90%2.77B
16.42%2.62B
14.06%2.7B
Liabilities
Current liabilities
Short term loan
-93.34%20.02M
-81.31%56.21M
-44.43%55.62M
-86.70%20.02M
66.53%300.55M
57.10%300.83M
11.89%100.1M
246.59%150.56M
315.02%180.48M
332.59%191.49M
Transactional financial liabilities
----
----
----
----
----
----
----
----
--46K
--46K
Notes payable and accounts payable
-10.87%45.49M
-44.72%37.69M
-10.43%41.18M
-0.15%35.51M
-24.74%51.03M
38.07%68.18M
-35.46%45.97M
21.66%35.56M
77.25%67.81M
50.07%49.38M
-Accounts payable
-10.87%45.49M
-44.72%37.69M
-10.43%41.18M
-0.15%35.51M
-24.74%51.03M
38.07%68.18M
-35.46%45.97M
21.66%35.56M
77.25%67.81M
50.07%49.38M
Contract liabilities
-87.92%3.4M
-9.36%2.14M
-37.70%9.71M
36.74%3.17M
584.59%28.11M
4.21%2.37M
-20.79%15.58M
-21.20%2.32M
53.84%4.11M
-2.66%2.27M
Salaries payable
-7.76%21.63M
-25.36%19.92M
-9.76%38.86M
-25.71%36.09M
-38.30%23.44M
-2.17%26.69M
-8.45%43.06M
22.53%48.58M
20.32%38M
-7.26%27.28M
Taxs payable
55.19%22.82M
74.68%17.62M
126.42%6.33M
83.52%22.03M
-19.96%14.71M
-72.53%10.09M
-57.54%2.8M
-39.14%12M
29.67%18.37M
110.52%36.72M
Other payable (including interest and dividends)
97.78%14.69M
62.96%11.47M
-22.45%7.96M
-19.99%8.01M
-14.35%7.43M
-15.96%7.04M
12.75%10.26M
5.12%10.01M
8.96%8.67M
-60.16%8.37M
-Other payable
97.78%14.69M
----
-22.45%7.96M
----
-14.35%7.43M
----
12.75%10.26M
----
9.55%8.67M
----
Other current liabilities
8.63%48.99M
50.45%63.22M
-23.64%46.16M
-15.18%46.33M
-2.15%45.1M
-7.75%42.02M
13.60%60.46M
125.09%54.62M
428.59%46.09M
1,036.71%45.55M
Total current liabilities
-62.36%177.04M
-54.45%208.27M
-26.03%205.81M
-45.43%171.16M
29.37%470.37M
26.61%457.2M
-6.12%278.22M
85.85%313.66M
147.60%363.58M
138.54%361.1M
Current liabilities
Deferred tax liabilities
-7.92%4.22M
-9.68%4.31M
-8.90%4.52M
989.22%4.39M
946.56%4.58M
964.95%4.77M
963.30%4.96M
5.52%403.18K
3.50%437.65K
-2.08%447.81K
Long term deferred income
5.64%90.18M
-5.03%82.99M
-8.40%81.85M
-7.23%83.4M
-6.25%85.37M
-5.29%87.38M
-4.36%89.35M
-2.66%89.9M
-2.28%91.06M
-1.90%92.26M
Total non current liabilities
4.95%94.4M
-5.27%87.29M
-8.43%86.36M
-2.79%87.79M
-1.69%89.95M
-0.60%92.15M
0.45%94.31M
-2.63%90.3M
-2.25%91.5M
-1.90%92.71M
Total liabilities
-51.56%271.43M
-46.20%295.56M
-21.57%292.17M
-35.90%258.95M
23.13%560.32M
21.05%549.35M
-4.54%372.53M
54.47%403.96M
89.26%455.08M
84.56%453.81M
Shareholders equity
Paid-in capital
0.00%1.28B
0.00%1.28B
0.00%1.28B
0.00%1.28B
0.00%1.28B
0.00%1.28B
0.00%1.28B
0.00%1.28B
0.00%1.28B
0.00%1.28B
Capital reserve funds
14.78%41.65M
14.78%41.65M
14.78%41.65M
37.08%40.07M
23.51%36.29M
23.51%36.29M
23.51%36.29M
14.77%29.23M
15.37%29.38M
15.37%29.38M
Surplus reserve funds
5.52%289.24M
5.52%289.24M
5.52%289.24M
12.87%274.11M
12.87%274.11M
12.87%274.11M
12.87%274.11M
3.77%242.85M
3.77%242.85M
3.77%242.85M
Retained profit
9.75%906.8M
3.37%978.09M
1.60%873.98M
8.20%905.1M
7.32%826.27M
11.80%946.16M
19.80%860.22M
13.70%836.47M
21.26%769.92M
12.82%846.29M
Less:Treasury stock
467.77%170.86M
--170.86M
--30.09M
--30.09M
-79.25%30.09M
----
----
----
0.00%145.05M
-5.90%145.05M
Other composite income
18.65%-386.02K
-782.08%-967.01K
648.91%355.7K
-19.60%-1.63M
-116.27%-474.5K
-103.80%-109.63K
-102.91%-64.8K
-50.33%-1.36M
425.06%2.92M
436.95%2.88M
Shareholders equity without minority interests
-1.66%2.35B
-4.70%2.42B
0.19%2.45B
3.37%2.47B
9.45%2.39B
12.42%2.54B
15.19%2.45B
12.12%2.39B
7.47%2.18B
5.70%2.26B
Minority interests
156.55%12.61M
183.83%16.22M
211.99%18.98M
158.76%11.92M
-46.71%-22.3M
-67.60%-19.34M
-86.42%-16.95M
1.01%-20.29M
18.08%-15.2M
20.18%-11.54M
Total shareholder equity
-0.20%2.36B
-3.33%2.43B
1.66%2.47B
4.76%2.48B
9.19%2.36B
12.13%2.52B
14.88%2.43B
12.24%2.37B
7.71%2.16B
5.88%2.24B
Total liabilityies and equity
-10.04%2.63B
-11.01%2.73B
-1.42%2.77B
-1.17%2.74B
11.61%2.92B
13.63%3.07B
11.86%2.81B
16.90%2.77B
16.42%2.62B
14.06%2.7B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Notarized Tianye Certified Public Accountants (Special General Partnership)
--
--
--
Notarized Tianye Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Assets
Current assets
Money funds 28.46%546.18M45.44%684.25M40.80%576.23M-8.68%464.69M-28.80%425.17M-42.57%470.47M-33.76%409.26M-3.71%508.86M21.04%597.19M76.09%819.18M
Transactional financial assets 95.50%94.32M-51.50%52.53M6.68%71.98M-69.47%38.1M-7.60%48.24M125.19%108.31M-1.10%67.48M33.30%124.78M25.25%52.21M-71.33%48.1M
Notes receivable and accounts receivable -20.34%309.78M-42.90%286.03M-59.38%231.93M-41.95%277.47M-32.94%388.88M13.78%500.96M39.15%571.04M27.28%477.98M67.34%579.94M45.01%440.31M
-Notes receivable -56.03%3.8M-27.82%8.2M15.68%6.9M-22.13%6.05M-63.17%8.64M-44.77%11.37M-59.29%5.96M--7.76M--23.46M--20.58M
-Accounts receivable -19.53%305.98M-43.25%277.83M-60.18%225.03M-42.28%271.42M-31.67%380.24M16.65%489.6M42.80%565.08M25.21%470.22M60.57%556.48M38.24%419.73M
Other receivables (including interest and dividends) 53.25%6.48M20.85%4.63M580.26%16.9M773.70%17.86M53.34%4.23M54.39%3.83M-3.01%2.48M-57.29%2.04M-46.09%2.76M-67.78%2.48M
-Accrued interest receivable --1.12M------------------------------------
-Other receivable 26.69%5.35M----580.26%16.9M----53.34%4.23M-----3.01%2.48M-----45.59%2.76M----
Advance payment -7.90%18.37M-80.28%8.45M-85.90%3.9M-47.72%31.43M-51.99%19.94M-10.63%42.85M16.88%27.67M74.41%60.12M35.15%41.54M75.89%47.95M
Inventories -40.39%456.03M-29.60%499.15M12.21%602.01M36.51%674.95M113.80%765.08M120.61%709.03M33.91%536.48M22.13%494.42M-14.40%357.85M-22.82%321.4M
Receivable financing -40.38%36.04M-25.47%43.4M-29.50%43.59M-42.35%23.42M360.52%60.46M156.41%58.23M65.76%61.82M-20.96%40.64M-64.30%13.13M-74.76%22.71M
Non-current assets due within one year --20.9M------64.95M----------------------------
Other current assets 1,236.12%4.39M-92.89%1.19M31.15%14.49M82.29%573.53K-97.57%328.93K81.44%16.76M17.89%11.05M-22.70%314.63K1,822.37%13.55M67.10%9.24M
Total current assets -12.84%1.49B-17.32%1.58B-3.63%1.63B-10.57%1.53B3.27%1.71B11.63%1.91B7.47%1.69B14.44%1.71B20.77%1.66B15.36%1.71B
Non Current assets
Debt investment -19.27%200.17M2.10%209.08M30.25%197.24M179.27%279.27M--247.93M545.15%204.78M375.05%151.44M--100M------31.74M
Long-term equity investment -19.05%2.27M23.43%5.51M11.86%5.98M-29.80%2.89M-46.48%2.81M-45.26%4.47M-38.44%5.34M-11.17%4.12M7.54%5.24M-13.89%8.16M
Fixed assets -1.52%528.28M-----1.64%553.08M-----1.87%536.46M-----1.79%562.29M----9.91%546.68M----
Constru in process -89.97%5.96M-----84.86%8.19M-----9.38%59.42M----37.87%54.1M-----19.90%65.58M----
Intangible assets 14.08%111.19M13.17%112.19M12.17%113.14M-10.87%91.37M-6.13%97.46M-5.84%99.13M-5.67%100.86M-5.58%102.51M-5.72%103.83M-6.24%105.28M
Development expenditure 65.00%86.25M84.22%76.47M86.25%70.16M57.74%55.58M67.98%52.27M51.63%41.51M51.86%37.67M54.98%35.23M68.23%31.12M107.05%27.38M
Goodwill 0.00%11.14M0.00%11.14M0.00%11.14M0.00%11.14M0.00%11.14M0.00%11.14M0.00%11.14M0.00%11.14M0.00%11.14M0.00%11.14M
Long deferred expense 12.57%23.4M3.78%22.52M4.18%23.6M-14.05%19.9M-5.47%20.79M-1.03%21.7M2.80%22.66M-8.00%23.15M-15.53%21.99M-14.57%21.92M
Deferred tax assets -6.62%91.24M-4.45%93.28M-10.80%90.53M-4.63%96.5M-1.00%97.71M1.21%97.62M2.08%101.49M2.79%101.19M-2.56%98.7M-6.36%96.45M
Other non current assets -9.01%77.9M8.26%69.75M-6.46%67.05M24.51%90.9M10.82%85.62M-17.54%64.43M228.62%71.67M145.37%73M198.31%77.25M203.29%78.13M
Total non current assets -6.09%1.14B-0.58%1.15B1.92%1.14B13.96%1.21B26.01%1.21B17.10%1.16B19.20%1.12B21.10%1.06B9.62%961.53M11.87%987.06M
Total assets -10.04%2.63B-11.01%2.73B-1.42%2.77B-1.17%2.74B11.61%2.92B13.63%3.07B11.86%2.81B16.90%2.77B16.42%2.62B14.06%2.7B
Liabilities
Current liabilities
Short term loan -93.34%20.02M-81.31%56.21M-44.43%55.62M-86.70%20.02M66.53%300.55M57.10%300.83M11.89%100.1M246.59%150.56M315.02%180.48M332.59%191.49M
Transactional financial liabilities ----------------------------------46K--46K
Notes payable and accounts payable -10.87%45.49M-44.72%37.69M-10.43%41.18M-0.15%35.51M-24.74%51.03M38.07%68.18M-35.46%45.97M21.66%35.56M77.25%67.81M50.07%49.38M
-Accounts payable -10.87%45.49M-44.72%37.69M-10.43%41.18M-0.15%35.51M-24.74%51.03M38.07%68.18M-35.46%45.97M21.66%35.56M77.25%67.81M50.07%49.38M
Contract liabilities -87.92%3.4M-9.36%2.14M-37.70%9.71M36.74%3.17M584.59%28.11M4.21%2.37M-20.79%15.58M-21.20%2.32M53.84%4.11M-2.66%2.27M
Salaries payable -7.76%21.63M-25.36%19.92M-9.76%38.86M-25.71%36.09M-38.30%23.44M-2.17%26.69M-8.45%43.06M22.53%48.58M20.32%38M-7.26%27.28M
Taxs payable 55.19%22.82M74.68%17.62M126.42%6.33M83.52%22.03M-19.96%14.71M-72.53%10.09M-57.54%2.8M-39.14%12M29.67%18.37M110.52%36.72M
Other payable (including interest and dividends) 97.78%14.69M62.96%11.47M-22.45%7.96M-19.99%8.01M-14.35%7.43M-15.96%7.04M12.75%10.26M5.12%10.01M8.96%8.67M-60.16%8.37M
-Other payable 97.78%14.69M-----22.45%7.96M-----14.35%7.43M----12.75%10.26M----9.55%8.67M----
Other current liabilities 8.63%48.99M50.45%63.22M-23.64%46.16M-15.18%46.33M-2.15%45.1M-7.75%42.02M13.60%60.46M125.09%54.62M428.59%46.09M1,036.71%45.55M
Total current liabilities -62.36%177.04M-54.45%208.27M-26.03%205.81M-45.43%171.16M29.37%470.37M26.61%457.2M-6.12%278.22M85.85%313.66M147.60%363.58M138.54%361.1M
Current liabilities
Deferred tax liabilities -7.92%4.22M-9.68%4.31M-8.90%4.52M989.22%4.39M946.56%4.58M964.95%4.77M963.30%4.96M5.52%403.18K3.50%437.65K-2.08%447.81K
Long term deferred income 5.64%90.18M-5.03%82.99M-8.40%81.85M-7.23%83.4M-6.25%85.37M-5.29%87.38M-4.36%89.35M-2.66%89.9M-2.28%91.06M-1.90%92.26M
Total non current liabilities 4.95%94.4M-5.27%87.29M-8.43%86.36M-2.79%87.79M-1.69%89.95M-0.60%92.15M0.45%94.31M-2.63%90.3M-2.25%91.5M-1.90%92.71M
Total liabilities -51.56%271.43M-46.20%295.56M-21.57%292.17M-35.90%258.95M23.13%560.32M21.05%549.35M-4.54%372.53M54.47%403.96M89.26%455.08M84.56%453.81M
Shareholders equity
Paid-in capital 0.00%1.28B0.00%1.28B0.00%1.28B0.00%1.28B0.00%1.28B0.00%1.28B0.00%1.28B0.00%1.28B0.00%1.28B0.00%1.28B
Capital reserve funds 14.78%41.65M14.78%41.65M14.78%41.65M37.08%40.07M23.51%36.29M23.51%36.29M23.51%36.29M14.77%29.23M15.37%29.38M15.37%29.38M
Surplus reserve funds 5.52%289.24M5.52%289.24M5.52%289.24M12.87%274.11M12.87%274.11M12.87%274.11M12.87%274.11M3.77%242.85M3.77%242.85M3.77%242.85M
Retained profit 9.75%906.8M3.37%978.09M1.60%873.98M8.20%905.1M7.32%826.27M11.80%946.16M19.80%860.22M13.70%836.47M21.26%769.92M12.82%846.29M
Less:Treasury stock 467.77%170.86M--170.86M--30.09M--30.09M-79.25%30.09M------------0.00%145.05M-5.90%145.05M
Other composite income 18.65%-386.02K-782.08%-967.01K648.91%355.7K-19.60%-1.63M-116.27%-474.5K-103.80%-109.63K-102.91%-64.8K-50.33%-1.36M425.06%2.92M436.95%2.88M
Shareholders equity without minority interests -1.66%2.35B-4.70%2.42B0.19%2.45B3.37%2.47B9.45%2.39B12.42%2.54B15.19%2.45B12.12%2.39B7.47%2.18B5.70%2.26B
Minority interests 156.55%12.61M183.83%16.22M211.99%18.98M158.76%11.92M-46.71%-22.3M-67.60%-19.34M-86.42%-16.95M1.01%-20.29M18.08%-15.2M20.18%-11.54M
Total shareholder equity -0.20%2.36B-3.33%2.43B1.66%2.47B4.76%2.48B9.19%2.36B12.13%2.52B14.88%2.43B12.24%2.37B7.71%2.16B5.88%2.24B
Total liabilityies and equity -10.04%2.63B-11.01%2.73B-1.42%2.77B-1.17%2.74B11.61%2.92B13.63%3.07B11.86%2.81B16.90%2.77B16.42%2.62B14.06%2.7B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Notarized Tianye Certified Public Accountants (Special General Partnership)------Notarized Tianye Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg